CLIA Lab Accreditors Reveal Most Frequent Deficiencies

By Scott Wallask | From the Volume XXX, No. 8 – May 30, 2023 Issue

CEO SUMMARY: CAP, The Joint Commission, COLA, and A2LA took the stage at the recent Executive War College to detail their respective lists of the 10 most often-cited standards during…

Read More

---

Payers Request More Claims Documentation

By Robert Michel | From the Volume XXX, No. 7 – May 8, 2023 Issue

CEO SUMMARY: Both anecdotal evidence from lab professionals and numbers-based data from XiFin point to a problem: More payers require clinical labs to produce more documentation that a test claim i…

Read More

---

Draft Rule Standardizes Electronic Signatures

By Robert Michel | From the Volume XXX, No. 6 – April 17, 2023 Issue

CEO SUMMARY: Every year, payers refuse laboratory test claims on grounds that the ordering provider’s signature is missing or illegible—a situation that costs clinical labs million of dollars in…

Read More

---

Six Important Themes to Help Labs Succeed

By Scott Wallask | From the Volume XXX, No. 5 – March 27, 2023 Issue

CEO SUMMARY: Clinical laboratories face business challenges with day-to-day operations, genetic testing, and evolving care delivery models. The 2023 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management returns on April 25-26 in New Orleans. Participant…

Read More

---

Elizabeth Holmes’ Appeal Questions Competence of CLIA Lab Director

By Scott Wallask | From the Volume XXX No. 4 – March 6, 2023 Issue

TANTALIZING DETAILS ABOUT FORMER THERANOS CEO ELIZABETH HOLMES’ purchase of a one-way plane ticket to Mexico prior to her conviction grabbed headlines following the filing of a motion to appeal her conviction.  However, for clinical labo…

Read More

---

Labcorp to Pay $19m to Settle Whistleblower Allegations

By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue

LABCORP AGREED TO SETTLE WHISTLEBLOWER ALLEGATIONS that it violated the False Claims Act by allowing its phlebotomists to draw blood from patients when the company allegedly knew kickbacks were behind the test orders for other lab firms. As part of the settlement, Labcorp in Burli…

Read More

---

CLIA on Path to Recognize Lab Data As a Specimen

By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue

CEO SUMMARY: Discussions within the federal Clinical Laboratory Improvement Advisory Committee (CLIAC) are focusing on digital diagnostic data and clinical laboratory testing conducted remotely. CLIAC recommendations about these important topics may eventually be part of updates to …

Read More

---

Congress Averts PAMA Cuts to Lab Test Rates for 2023

By Scott Wallask | From the Volume XXX, No. 1 – January 3, 2023 Issue

CONGRESS ENACTED LEGISLATION LAST MONTH that suspends implementation of the next round of price cuts to the Medicare Part B Clinical Laboratory Fee Schedule (CLFS) that was scheduled to take effect on Jan. 1. This is a welcome development for the medical laboratory industry….

Read More

---

Holmes, Balwani Get Lengthy Prison Terms for Theranos Fraud

By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue

SENTENCING OF ELIZABETH HOLMES AND RAMESH “SUNNY” BALWANI in federal court caps the strange, yet captivating, saga of Theranos and its flawed blood testing technology. For laboratory professionals, the four years of legal wranglings that surrounded the Theranos fraud case may be remembered …

Read More

---

VALID and SALSA Acts Still Pending in Congress

By Robert Michel | From the Volume XXIX, No. 16 – November 21, 2022 Issue

CEO SUMMARY: Both the pending VALID Act and SALSA Act continue to push ahead as 2022 comes to an end. Meanwhile, a new bill centered on the Physician Fee Schedule may protect pathologist payments. These three different proposals share something in common:…

Read More

---